STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$98,653
-38.9%
31,418
+0.4%
0.00%
Q2 2023$161,394
-2.1%
31,2780.0%0.00%
Q1 2023$164,835
+87.5%
31,2780.0%0.00%
Q4 2022$87,891
-32.4%
31,2780.0%0.00%
Q3 2022$130,000
+3.2%
31,2780.0%0.00%
Q2 2022$126,000
-18.7%
31,278
+0.0%
0.00%
Q1 2022$155,000
-28.9%
31,2680.0%0.00%
Q4 2021$218,000
-29.9%
31,268
+0.5%
0.00%
-100.0%
Q3 2021$311,000
-29.5%
31,1170.0%0.00%0.0%
Q2 2021$441,000
+8.6%
31,117
+25.8%
0.00%0.0%
Q1 2021$406,000
-20.7%
24,7360.0%0.00%0.0%
Q4 2020$512,000
+319.7%
24,736
+54.8%
0.00%
Q3 2020$122,000
-8.3%
15,9760.0%0.00%
Q2 2020$133,000
+114.5%
15,976
+28.1%
0.00%
Q1 2020$62,000
+34.8%
12,470
+7.8%
0.00%
Q4 2019$46,000
+31.4%
11,5700.0%0.00%
Q3 2019$35,000
-31.4%
11,5700.0%0.00%
Q2 2019$51,000
+10.9%
11,5700.0%0.00%
Q1 2019$46,0000.0%11,5700.0%0.00%
Q4 2018$46,000
-42.5%
11,5700.0%0.00%
Q3 2018$80,000
+2.6%
11,5700.0%0.00%
Q2 2018$78,000
+5.4%
11,570
+2.3%
0.00%
Q1 2018$74,000
+48.0%
11,3100.0%0.00%
Q4 2017$50,000
-28.6%
11,3100.0%0.00%
Q3 2017$70,000
-33.3%
11,3100.0%0.00%
Q2 2017$105,00011,3100.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders